Immunome Inc. (IMNM)
10.12
0.74 (7.89%)
At close: Jan 15, 2025, 3:59 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -106.81M | -36.90M | -24.71M | -17.84M | -10.44M | -7.84M |
| Depreciation & Amortization | 728.00K | 631.00K | 755.00K | 755.00K | 615.00K | 521.00K |
| Stock-Based Compensation | 6.22M | 5.33M | 3.45M | 621.00K | 14.00K | 11.00K |
| Other Working Capital | 12.61M | 2.92M | 998.00K | -1.71M | 137.00K | -248.00K |
| Other Non-Cash Items | 80.29M | 7.27M | 4.00K | -2.00K | 3.00K | 9.00K |
| Deferred Income Tax | n/a | -7.27M | -500.00K | 5.54M | n/a | n/a |
| Change in Working Capital | 12.00M | 2.24M | 2.78M | -1.21M | 212.00K | -102.00K |
| Operating Cash Flow | -7.57M | -28.69M | -18.23M | -12.13M | -9.60M | -7.41M |
| Capital Expenditures | -831.00K | -248.00K | -79.00K | -586.00K | -233.00K | -228.00K |
| Acquisitions | 9.28M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -38.93M | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -30.48M | -248.00K | -79.00K | -586.00K | -233.00K | -228.00K |
| Debt Repayment | n/a | n/a | -113.00K | 49.00K | 6.19M | -551.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -35.00K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 116.37M | 32.00K | 656.00K | 5.04M | 4.59M | n/a |
| Financial Cash Flow | 116.41M | 32.00K | 27.77M | 49.94M | 10.77M | -551.00K |
| Net Cash Flow | 78.36M | -28.91M | 9.46M | 37.22M | 941.00K | -8.19M |
| Free Cash Flow | -8.40M | -28.94M | -18.30M | -12.72M | -9.83M | -7.63M |